Sökresultat - Shang‐Gin Wu

  • Visas 1 - 18 av 18 resultat
Förfina resultatet
  1. 1
    Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

    Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer av Shang‐Gin Wu, Jin‐Yuan Shih

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    MicroRNA in Lung Cancer Metastasis

    MicroRNA in Lung Cancer Metastasis av Shang‐Gin Wu, Tzu‐Hua Chang, Yinan Liu, Jin‐Yuan Shih

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Good Response to Gefitinib in Lung Adenocarcinoma Harboring Coexisting EML4-ALK Fusion Gene and EGFR Mutation

    Good Response to Gefitinib in Lung Adenocarcinoma Harboring Coexisting EML4-ALK Fusion Gene and EGFR Mutation av Yao-Wen Kuo, Shang‐Gin Wu, Chao‐Chi Ho, Jin‐Yuan Shih

    Publicerad 2010
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition

    The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition av Shang‐Gin Wu, Yih‐Leong Chang, Chong‐Jen Yu, Pan‐Chyr Yang, Jin‐Yuan Shih

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Lung adenocarcinoma patients of young age have lower <i>EGFR</i> mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors

    Lung adenocarcinoma patients of young age have lower <i>EGFR</i> mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors av Shang‐Gin Wu, Yih‐Leong Chang, Chong‐Jen Yu, Pan‐Chyr Yang, Jin‐Yuan Shih

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

    EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway av Meng-Feng Tsai, Tzu-Hua Chang, Shang-Gin Wu, Hsiao-Yin Yang, Yi‐Chiung Hsu, Pan‐Chyr Yang, Jin‐Yuan Shih

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer

    Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer av Yen‐Ting Lin, Yu‐Fen Wang, James Chih‐Hsin Yang, Chong‐Jen Yu, Shang‐Gin Wu, Jin‐Yuan Shih, Pan‐Chyr Yang

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

    miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway av Yinan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Tzu‐Hsiu Tsai, Chien‐Hung Gow, Hsin‐Yi Wang, Jin‐Yuan Shih

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

    Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer av Yi‐Nan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Tzu‐Hsiu Tsai, Chien‐Hung Gow, Yih‐Leong Chang, Jin‐Yuan Shih

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response

    Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response av Jenn‐Yu Wu, Shang‐Gin Wu, James Chih‐Hsin Yang, Chien‐Hung Gow, Yih‐Leong Chang, Chong‐Jen Yu, Jin‐Yuan Shih, Pan‐Chyr Yang

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Survival of lung adenocarcinoma patients with malignant pleural effusion

    Survival of lung adenocarcinoma patients with malignant pleural effusion av Shang‐Gin Wu, Chong‐Jen Yu, Meng‐Feng Tsai, Wei‐Yu Liao, James Chih‐Hsin Yang, I‐Shiow Jan, Pan‐Chyr Yang, Jin‐Yuan Shih

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR

    Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR av Kuei‐Pin Chung, Shang‐Gin Wu, Jenn‐Yu Wu, James Chih‐Hsin Yang, Chong‐Jen Yu, Pin‐Fei Wei, Jin‐Yuan Shih, Pan‐Chyr Yang

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations

    Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populat... av Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu, Yih‐Leong Chang, Chong‐Jen Yu, James Chih‐Hsin Yang, Pan‐Chyr Yang, Jin‐Yuan Shih

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

    LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis av Yi‐Ling Chen, Yinan Liu, Yen‐Ting Lin, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Chia‐Lang Hsu, Huey‐Dong Wu, Jin‐Yuan Shih

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

    IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer av Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hsiu Tsai, Hsuan‐Yu Chen, Sung‐Liang Yu, James Chih‐Hsin Yang, Jin‐Yuan Shih

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR

    EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR av Shang‐Gin Wu, Yao-Wen Kuo, Yih‐Leong Chang, Jin‐Yuan Shih, Yahui Chen, Meng‐Feng Tsai, Chong‐Jen Yu, James Chih‐Hsin Yang, Pan‐Chyr Yang

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

    The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients av Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai, Yih‐Leong Chang, Chong‐Jen Yu, Pan‐Chyr Yang, James Chih‐Hsin Yang, Yueh‐Feng Wen, Jin‐Yuan Shih

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations

    Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations av Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu, Yih‐Leong Chang, Jin‐Yuan Shih, Yinan Liu, Meng‐Feng Tsai, Tzu‐Hsiu Tsai, Chong‐Jen Yu, James Chih‐Hsin Yang, Pan‐Chyr Yang

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: